Bonactive Team, Ming Chi University of Science and Technology (MCUT) negotiated with Maxigen Biotech Inc. (MBI) for the trial production line for an artificial bone graft

The R&D team composed of professors and students of Ming Chi University of Technology's International Ph.D. Program in Biomedical Engineering negotiated with Maxigen Biotech Company on December 29, 2023. The content of the cooperation between the two entities is the trial production plant for the bioglass ceramic.

Ming Chi University of Technology said that the Bonactive Team is composed of professors and students of the university's International Ph.D. Program in Biomedical Engineering. With the aid of the university's resources, the team successfully developed the "Bone Powder of Glass-Ceramic Composites" made of self-developed high-porosity composite ceramic materials that is capable of releasing active ions and has the advantage of strengthening the osseointegration speed compared with the existing bone powder on the market. Bonactive Team also participated in the FITI Innovation and Entrepreneurship Incentive Program of the National Science and Technology Council and entered the top 20 teams in the country, with promising development prospects.

Prof. Pin-Yi Chen, the supervising professor of the Bonactive Team of Ming Chi University of Technology, said that after 3 years of research and development, the results of bioglass ceramic synthetic bone materials have been affirmed, and the team won the silver medal in the 2023 Taiwan Innovation Technology Expo. The team also won the Excellence Award in the 2023 Annual Industry-University Cooperation Plan Achievement Publication and Performance Appraisal Conference of the National Science and Technology Council. Furthermore, the cooperation between the Bonactive Team and MBI can optimize the product efficacy of Maxigen Biotech Company's bone graft product positioning. The cooperation with MBI for the trial production plant hopes to introduce the product process technology into MBI, which is another milestone for Ming Chi University of Technology to implement commercialization technology to actual commercial mass production.

Ming Chi University of Technology said that it is very important for students to have a clear outlet for what they have learned; hence, an avenue is provided to them through the guidance and subsidy of the university's Industry-University Development Center and the links of various external resources. The cooperation with Maxigen Biotech is also expected to make good use of each other's advantages and continue to deepen the cooperative relationship with each other under the common goal of developing a bone graft production line and jointly expand more business opportunities.

Picture 1: Group photo of Prof. Pin-Yi Chen (5th from the left) of the Bonactive team, Vice President Pai-Hong Lai (4th from the left) and the Maxigen Biotech team.

Picture 2: Group photo of the meeting held with the Industrial Development Center of MCUT, the Bonactive team, and the Maxigen Biotech team.